Equities

Well Lead Medical Co Ltd

603309:SHH

Well Lead Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)10.19
  • Today's Change-3.46 / -25.35%
  • Shares traded2.55m
  • 1 Year change-29.29%
  • Beta0.7157
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments447700635
Total Receivables, Net215113154
Total Inventory143163168
Prepaid expenses121618
Other current assets, total0.011.580.01
Total current assets817994975
Property, plant & equipment, net857597586
Goodwill, net293293293
Intangibles, net168173183
Long term investments42929073
Note receivable - long term------
Other long term assets3.223.141.10
Total assets2,6052,3842,132
LIABILITIES
Accounts payable157161113
Accrued expenses977965
Notes payable/short-term debt9213396
Current portion long-term debt/capital leases9.867.1056
Other current liabilities, total869797
Total current liabilities441477427
Total long term debt28713792
Total debt388278244
Deferred income tax12115.57
Minority interest201613
Other liabilities, total291917
Total liabilities788660554
SHAREHOLDERS EQUITY
Common stock293293293
Additional paid-in capital651652633
Retained earnings (accumulated deficit)905812685
Treasury stock - common(8.24)(14)(24)
Unrealized gain (loss)(23)(19)(8.82)
Other equity, total------
Total equity1,8171,7241,578
Total liabilities & shareholders' equity2,6052,3842,132
Total common shares outstanding291290260
Treasury shares - common primary issue2.093.693.79
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.